CD274 and neoplasm: Among these, PD-L1 expression has been investigated as a key biomarker, with higher expression levels generally correlating with improved response to checkpoint inhibitors, though its predictive value remains inconsistent due to heterogeneity in detection methods and tumor biology (17, 18).